Makers Laboratories Quarterly Results for Trading Insights

MAKERSL • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹1 Cr
QSept 2025
Quarterly Results

Makers Laboratories Quarterly Results Key Highlights

  • Revenue of ₹35 Cr in Sept 2025 (+2.9% vs Mar 2025, -12.5% vs Sept 2024)
  • Net Profit of ₹1 Cr in Sept 2025 (-50.0% vs Mar 2025, -90.0% vs Sept 2024)
  • EBITDA of ₹3 Cr in Sept 2025 (+0.0% vs Mar 2025)
  • Operating Margin of 7.0% in Sept 2025 (-2.0pp vs Mar 2025)
  • Earnings Per Share of ₹-0.20 in Sept 2025 (-150.0% vs Mar 2025)

Makers Laboratories Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Sept 2024 Mar 2024 QoQ YoY
Revenue (₹ Cr) 35 34 35 40 28 2.9% -12.5%
Net Profit (₹ Cr) 1 2 1 10 -1 - -
EBITDA (₹ Cr) 3 3 3 13 1 - -
EPS (₹) -0.20 -0.08 0.74 14.94 -2.18 - -
Operating Margin (%) 7.0% 9.0% 9.0% 7.0% 3.0% - -

Makers Laboratories Share Price Trend Around Quarterly Results

Visualize Makers Laboratories's 1-year price movement across quarterly results — ideal for logging trades in Makers Laboratories share price chart using Tickjournal. All values in ₹.

Profitability Ratios

Profit Margin 2.9%
EBITDA Margin 8.6%
Operating Margin 7.0%
ROE (Annual) 3.5%

Balance Sheet Highlights

Total Assets ₹148 Cr
Total Equity ₹115 Cr
Current Assets ₹68 Cr
Current Liabilities ₹12 Cr

Cash Flow Analysis

Operating Cash Flow ₹-4 Cr
Investing Cash Flow ₹20 Cr
Financing Cash Flow ₹-16 Cr
Net Cash Flow ₹0 Cr

Current Market Data

Current Price ₹117.65
Exchange BSE
Last Updated Jan 09, 2026

Sector Competitors - Quarterly Performance Comparison

Comparing Makers Laboratories quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025
₹417,052.40 Cr 1729.9 14,875 3,125 +10.8% - 21.0% 133.1
Divis Laboratories
Sept 2025
₹176,337.50 Cr 6616.5 2,860 689 +7.1% - 24.1% 254.8
Torrent Pharmaceuti…
Sept 2025
₹136,522.12 Cr 3963.4 3,219 591 +11.3% - 18.4% 226.0
Cipla
Sept 2025
₹118,572.82 Cr 1465.7 7,716 1,353 +12.0% - 17.5% 87.6
Dr Reddys Laborator…
Sept 2025
₹100,998.62 Cr 1210.1 9,135 1,337 +1.1% - 14.6% 74.8
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores